CLINICAL_TRIALS
trial_result
· 2021-02-21
Clinical Trial Update: Lorlatinib Renal Impairment Study [Phase 1]
Summary
Phase 1 trial update examining lorlatinib in patients with renal impairment; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2021-02-21